news
Ministry of Health includes Polyoxidonium® in the federal clinical guidelines for ARVI treatment
On August 4, the Russian Ministry of Health approved an updated version of clinical guidelines for the treatment of acute respiratory viral infections (ARVI) in adults. One of the drugs for the treatment and prevention of ARVI included in the federal guidelines this year is Polyoxidonium® (azoximer bromide)
Authorities recommend including immuno-oncology drug Areima® for esophageal and nasopharyngeal cancer in VED
Petrovax Pharm launches Polyoxidonium® in drops
Camrelizumab in combination with paclitaxel and cisplatin can become a new standard of first-line therapy in patients with advanced or metastatic esophageal cancer
Sechenov University and Petrovax Pharm team up to increase access to innovative domestic medicines
Double punch to cancer
Moscow Region Government and Petrovax Pharm sign cooperation agreement
U.S. Geneticist Who Developed Enzyme Replacement Therapy for Fabry Disease Endorses the Russian Biosimilar Fabagal®
Experts predict more novel biotech drug launches in Russia’s market
